Add to ORKGThe present invention provides peptides which have the ability to bind hemagglutinin found on the surface of influenza viruses. This invention further provides use of the peptides as a medicament, for instance in the treatment and/or prevention of influenza A virus infection. Further provided are compositions comprising the peptides and methods for diagnosing influenza A virus infection and determining the type of an influenza virus
Influenza A virus is a particularly problematic virus because of its ability to cause high levels of...
Abstract Background Avian influenza viruses (AIV) cause high morbidity and mortality among the poult...
There is an urgent need for new drugs against influenza type A and B viruses due to incomplete prote...
The influenza virus infects mammals and birds. The first step of the infection cycle comprises the a...
Influenza A viruses are enveloped, segmented negative single-stranded RNA viruses, capable of causin...
Influenza A viruses are enveloped, segmented negative single-stranded RNA viruses, capable of causin...
Antibodies against spike proteins of influenza are used as a tool for characterization of viruses an...
Antibodies against spike proteins of influenza are used as a tool for characterization of viruses an...
The threat of a worldwide influenza pandemic has greatly increased over the past decade with the eme...
Antibodies that specifically bind influenza virus hemagglutinin A (HA), and antigen binding fragment...
Influenza viruses represent a leading cause of high morbidity and mortality worldwide. Approaches fo...
Avian influenza viruses (AIV), the causative agent of avian flu or bird flu, cause widespread morbid...
The present invention relates to recombinant phages carrying fusion peptides that bind to avian infl...
Respiratory virus infections, such as those caused by influenza, parainfluenza and respiratory sync...
Influenza A viruses pose a serious pandemic risk, while generation of efficient vaccines against sea...
Influenza A virus is a particularly problematic virus because of its ability to cause high levels of...
Abstract Background Avian influenza viruses (AIV) cause high morbidity and mortality among the poult...
There is an urgent need for new drugs against influenza type A and B viruses due to incomplete prote...
The influenza virus infects mammals and birds. The first step of the infection cycle comprises the a...
Influenza A viruses are enveloped, segmented negative single-stranded RNA viruses, capable of causin...
Influenza A viruses are enveloped, segmented negative single-stranded RNA viruses, capable of causin...
Antibodies against spike proteins of influenza are used as a tool for characterization of viruses an...
Antibodies against spike proteins of influenza are used as a tool for characterization of viruses an...
The threat of a worldwide influenza pandemic has greatly increased over the past decade with the eme...
Antibodies that specifically bind influenza virus hemagglutinin A (HA), and antigen binding fragment...
Influenza viruses represent a leading cause of high morbidity and mortality worldwide. Approaches fo...
Avian influenza viruses (AIV), the causative agent of avian flu or bird flu, cause widespread morbid...
The present invention relates to recombinant phages carrying fusion peptides that bind to avian infl...
Respiratory virus infections, such as those caused by influenza, parainfluenza and respiratory sync...
Influenza A viruses pose a serious pandemic risk, while generation of efficient vaccines against sea...
Influenza A virus is a particularly problematic virus because of its ability to cause high levels of...
Abstract Background Avian influenza viruses (AIV) cause high morbidity and mortality among the poult...
There is an urgent need for new drugs against influenza type A and B viruses due to incomplete prote...